GO:0015705 iodide transport: Thyroid Hormone Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015705 iodide transport describes the directed movement of iodide into, out of, or within a cell, or between cells, by means of a transporter or pore.
• The sodium/iodide symporter (SLC5A5/NIS) is the central transporter that mediates active iodide uptake in the thyroid gland and other tissues.
• Transepithelial iodide transport in the thyroid requires coordinated uptake at the basolateral membrane and efflux at the apical membrane, a process essential for thyroid hormone biosynthesis.
• Pendred syndrome, caused by mutations in SLC26A4 (pendrin), is a classic disease of defective iodide transport and is associated with congenital deafness and goiter.
• Iodide transport is also relevant in breast cancer, where NIS expression can influence iodide accumulation and potential radioiodide therapy.
• Experimental models for studying iodide transport include knockout mice, point-mutation knock-in cell lines, and overexpression systems for SLC5A5 and SLC26A4.
Description
Iodide transport (GO:0015705) is the biological process by which iodide ions are moved across cellular membranes or between cells via specific transporters or pores. This process is fundamental to thyroid physiology, as it provides the iodide required for the synthesis of thyroid hormones, which regulate metabolism, growth, and development. The directed movement of iodide is mediated by specialized proteins, most notably the sodium/iodide symporter (NIS, encoded by SLC5A5), which couples iodide uptake to the sodium gradient. Defects in iodide transport underlie several human diseases, including congenital hypothyroidism, Pendred syndrome, and certain cancers. Understanding the molecular mechanisms of iodide transport is therefore critical for both basic biology and clinical applications, including the development of targeted therapies and diagnostic tools.
iodide transport At A Glance
| GO ID | GO:0015705 |
|---|---|
| GO term | iodide transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of iodide across membranes via transporters or pores |
| Key transporters | SLC5A5 (NIS), SLC26A4 (pendrin), and other anion exchangers |
| Tissues | Thyroid, breast, salivary gland, gastric mucosa, large intestine |
| Disease relevance | Pendred syndrome, congenital hypothyroidism, thyroid cancer, breast cancer |
| Research methods | Radioiodide uptake assays, electrophysiology, knockout models, CRISPR screens |
What Is GO:0015705?
According to the Gene Ontology, GO:0015705 iodide transport is defined as the directed movement of iodide into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This process encompasses the translocation of iodide across biological membranes, which can occur through active transport, facilitated diffusion, or channel-mediated mechanisms. It is a biological process that is distinct from iodide metabolism or thyroid hormone synthesis, although it is a prerequisite for those downstream events in the thyroid gland.
Why Is iodide transport Important in Cell Biology?
Iodide transport is essential for thyroid hormone biosynthesis and thus for normal development and metabolism. It is also a key determinant of radioiodide uptake in thyroid cancer and other tissues, making it a target for diagnostic imaging and therapy. Moreover, inherited defects in iodide transport cause Pendred syndrome and other thyroid dysfunctions, highlighting its clinical significance.
• Provides iodide for thyroid hormone synthesis, which regulates basal metabolic rate, growth, and neuronal development.
• Mutations in SLC5A5 or SLC26A4 cause congenital hypothyroidism and Pendred syndrome.
• NIS-mediated iodide uptake is exploited in radioiodide therapy for thyroid cancer.
• Iodide transport in breast cancer may influence tumor behavior and response to radioiodide.
• The process is conserved across species and can be studied in model organisms and cell lines.
• Understanding iodide transport aids in the design of inhibitors or enhancers for therapeutic purposes.
• It is a paradigm for studying secondary active transport and anion selectivity.
• Iodide transport in the large intestine may contribute to epithelial chloride transport and fluid balance.
What Happens During iodide transport?
Basolateral iodide uptake
In simple terms: Iodide is actively pumped into the thyroid cell from the blood.
The sodium/iodide symporter (NIS, SLC5A5) located on the basolateral membrane of thyroid follicular cells couples the inward transport of iodide to the inward sodium gradient, concentrating iodide up to 20-40 times above plasma levels. This step is the rate-limiting step in thyroid hormone synthesis and is stimulated by TSH.
Intracellular iodide diffusion
In simple terms: Once inside, iodide moves to the other side of the cell.
After uptake, iodide diffuses within the cytoplasm toward the apical membrane, possibly facilitated by intracellular iodide-binding proteins or channel-like structures, although the exact mechanism remains incompletely understood.
Apical iodide efflux
In simple terms: Iodide is released into the follicle lumen for hormone production.
At the apical membrane, iodide is transported into the colloid by pendrin (SLC26A4) and possibly other anion exchangers, where it is oxidized by thyroperoxidase and incorporated into thyroglobulin. Defects in pendrin cause Pendred syndrome, characterized by goiter and deafness.
Iodide transport in non-thyroid tissues
In simple terms: Other organs also move iodide, but for different purposes.
NIS is expressed in salivary glands, gastric mucosa, breast, and large intestine, where iodide transport may serve diverse functions such as antimicrobial activity or iodide recycling. In the large intestine, iodide can be used as a surrogate tracer for chloride transport, indicating shared anion transport pathways.
Regulation of iodide transport
In simple terms: The process is turned up or down by hormones and cellular signals.
TSH is the primary regulator of thyroid iodide transport, increasing NIS expression and membrane targeting. Other factors, including iodine availability, cytokines, and growth factors, can modulate NIS activity and expression in thyroid and extrathyroidal tissues.
Key Genes Involved in GO:0015705 iodide transport
The following genes encode proteins that directly mediate or regulate iodide transport across cell membranes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC5A5 | Sodium/iodide symporter (NIS) that mediates active iodide uptake | Central to thyroid hormone synthesis; target for radioiodide therapy; mutated in congenital hypothyroidism |
| SLC26A4 | Pendrin, an anion exchanger that transports iodide at the apical membrane | Mutations cause Pendred syndrome; involved in iodide efflux |
| TPO | Thyroperoxidase, oxidizes iodide for incorporation into thyroglobulin | Not a transporter but essential for iodide utilization; mutations cause dyshormonogenesis |
| TG | Thyroglobulin, the substrate for iodination and hormone synthesis | Provides tyrosine residues for iodination; mutations cause goiter |
| TSHR | Thyroid-stimulating hormone receptor, regulates NIS expression and iodide transport | Autoantibodies cause Graves' disease; mutations cause hypothyroidism |
| PAX8 | Transcription factor regulating thyroid-specific genes including SLC5A5 | Mutations cause congenital hypothyroidism |
| NKX2-1 | Transcription factor important for thyroid development and NIS expression | Mutations cause benign hereditary chorea and thyroid dysfunction |
| FOXE1 | Transcription factor involved in thyroid morphogenesis | Mutations cause Bamforth-Lazarus syndrome |
| SLC26A7 | Anion transporter expressed in thyroid and other tissues | May contribute to iodide transport in specific contexts |
| CFTR | Chloride channel that may influence iodide transport in epithelial tissues | Relevant to iodide transport in large intestine and other epithelia |
| SLC12A2 | Sodium-potassium-chloride cotransporter, may affect iodide handling | Indirect role in anion transport |
| SLC4A2 | Anion exchanger, potentially involved in iodide transport | Expressed in thyroid and other tissues |
| ANO1 | Calcium-activated chloride channel, may transport iodide | Expressed in epithelial cells; potential iodide permeability |
| CLCN2 | Chloride channel, may contribute to iodide transport | Expressed in thyroid; role in anion transport |
| SLC26A3 | Chloride/iodide exchanger in the intestine | May mediate iodide transport in the gut |
| SLC26A6 | Anion exchanger with broad specificity including iodide | Expressed in kidney and intestine; potential iodide transport |
| SLC5A8 | Sodium-coupled monocarboxylate transporter, may transport iodide | Expressed in thyroid and other tissues |
| SLC22A2 | Organic cation transporter, may influence iodide distribution | Expressed in kidney; indirect role |
How Is iodide transport Regulated?
Iodide transport is primarily regulated by thyroid-stimulating hormone (TSH), which upregulates the expression and membrane localization of the sodium/iodide symporter (NIS) in thyroid follicular cells. This regulation ensures adequate iodide supply for thyroid hormone synthesis in response to metabolic demand. Additionally, iodide itself can autoregulate its transport through the Wolff-Chaikoff effect, where high iodide concentrations transiently inhibit organification and transport. In extrathyroidal tissues, NIS expression can be modulated by hormones such as prolactin and estrogen, as well as by cytokines and growth factors, although the physiological significance is less clear.
iodide transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC26A4 | Pendred syndrome (goiter, deafness) | Knockout mouse, patient-derived iPSCs, HEK293 knock-in |
| SLC5A5 | Congenital hypothyroidism due to iodide transport defect | Knockout mouse, thyroid cell lines (FRTL-5) with CRISPR KO |
| TPO | Dyshormonogenesis with goiter | Knockout mouse, overexpression in COS-7 cells |
| TSHR | Graves' disease, congenital hypothyroidism | Knock-in mouse models, cell-based assays |
| SLC26A7 | Potential role in iodide transport and thyroid function | Knockout mouse, overexpression in polarized epithelial cells |
Pendred syndrome and iodide transport defects
Pendred syndrome is an autosomal recessive disorder caused by mutations in SLC26A4, which encodes the anion transporter pendrin. Pendrin is critical for iodide efflux at the apical membrane of thyroid cells, and its dysfunction leads to impaired iodide organification, resulting in goiter and congenital sensorineural deafness. This condition highlights the importance of iodide transport in both thyroid and inner ear function.
Thyroid cancer and radioiodide therapy
The ability of thyroid cancer cells to accumulate iodide via NIS is exploited in radioiodide therapy, but many thyroid cancers lose NIS expression and become radioiodide-refractory. Understanding the mechanisms of iodide transport and its regulation is essential for developing strategies to restore NIS function and improve treatment outcomes.
Breast cancer and iodide transport
NIS is expressed in lactating breast and in some breast cancers, where it can mediate iodide uptake. This has raised interest in using radioiodide for breast cancer imaging and therapy, although the efficiency is often lower than in thyroid tissue. Research into iodide transport in breast cancer may lead to novel diagnostic and therapeutic approaches.
Congenital hypothyroidism due to iodide transport defects
Mutations in SLC5A5 can cause congenital hypothyroidism due to defective iodide uptake, a condition that can be treated with levothyroxine if diagnosed early. This underscores the clinical importance of iodide transport for normal development.
From iodide transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC5A5 mediate iodide uptake in a specific tissue? | SLC5A5 knockout cell line (e.g., HeLa or HEK293) with radioiodide uptake assay |
| What is the effect of a point mutation in SLC26A4 on iodide transport? | Knock-in of mutant SLC26A4 in HEK293 or patient fibroblasts |
| Can overexpression of NIS restore iodide uptake in thyroid cancer cells? | Lentiviral overexpression of SLC5A5 in BCPAP or FTC-133 cells |
| What is the role of pendrin in inner ear function? | SLC26A4 knockout mouse with auditory brainstem response testing |
| How does TSH regulate NIS membrane trafficking? | Tagged knock-in of SLC5A5 with GFP in thyroid cells, live-cell imaging |
| Which genes modify iodide transport in the intestine? | CRISPR library screening in Caco-2 cells with iodide-sensitive fluorescent probes |
How to Study the iodide transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioiodide uptake assay | Active iodide transport into cells | Functional validation of NIS and mutant transporters |
| Ussing chamber | Transepithelial iodide flux | Intestinal or thyroid epithelial transport studies |
| Patch-clamp | Ion channel activity and iodide permeability | Characterization of iodide-conducting channels |
| Fluorescent iodide sensors | Real-time intracellular iodide levels | Live-cell imaging and high-throughput screening |
| CRISPR knockout screen | Genes required for iodide transport | Discovery of novel regulators |
| RNA-seq | Expression of iodide transport genes | Tissue-specific expression profiling |
| Proteomics | Protein interactions and abundance | Identification of NIS-interacting proteins |
| Immunofluorescence | Subcellular localization of transporters | Polarized trafficking studies |
Radioiodide uptake assays
Radioiodide (125I or 131I) uptake assays are the gold standard for measuring iodide transport activity in cells and tissues. Cells are incubated with radioiodide, washed, and lysed, and radioactivity is quantified by gamma counting. This method can be used to assess the function of NIS and other transporters, as well as to screen for compounds that modulate iodide transport.
Electrophysiology and ion flux measurements
Patch-clamp and Ussing chamber techniques can measure iodide currents and transepithelial iodide flux directly. These methods provide real-time kinetic data and are particularly useful for studying channel-mediated iodide transport and the effects of mutations on transporter function.
Fluorescent iodide indicators
Genetically encoded or chemical fluorescent iodide sensors allow live-cell imaging of iodide transport dynamics. These tools enable high-throughput screening and spatial analysis of iodide movement within cells and tissues.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens coupled with iodide-sensitive readouts can identify novel genes regulating iodide transport. Such screens have the potential to uncover new therapeutic targets and clarify the genetic network underlying iodide homeostasis.
How CRISPR Can Be Used to Study GO:0015705 iodide transport
Knockout
CRISPR knockout of SLC5A5 or SLC26A4 in cell lines such as HEK293 or FRTL-5 can abolish iodide transport, providing a clean background to study transporter function and to test rescue constructs. Knockout models are also useful for identifying off-target effects of drugs and for validating specific roles of transporters in iodide uptake.
Point Mutation
Introducing disease-associated point mutations (e.g., in SLC26A4 or SLC5A5) via CRISPR base editing or homology-directed repair allows precise modeling of patient-specific defects. These models can reveal how single amino acid changes affect iodide transport kinetics, membrane trafficking, and protein stability.
Knock-in
Knock-in of tagged versions of SLC5A5 (e.g., GFP or HA) enables real-time tracking of transporter localization and dynamics in live cells. Knock-in of reporter genes under the endogenous SLC5A5 promoter can also be used to study transcriptional regulation by TSH and other factors.
Overexpression
Overexpression of SLC5A5 or SLC26A4 in cell lines that normally lack iodide transport (e.g., COS-7, HeLa) can reconstitute iodide uptake and efflux, facilitating structure-function studies and drug screening. Overexpression models are also valuable for producing large amounts of transporter protein for biochemical assays.
How EDITGENE Supports iodide transport Research
Researchers studying iodide transport-related genes often need to determine whether a candidate gene is causally involved in iodide uptake, efflux, or regulation. CRISPR-based models provide a robust way to manipulate these genes in relevant cell types, enabling precise functional interrogation and disease modeling.
Contact EDITGENE today to design your custom CRISPR model for iodide transport research.
Frequently Asked Questions About iodide transport
What is iodide transport?
Iodide transport is the directed movement of iodide ions across cell membranes or between cells via transporters or pores, as defined by GO:0015705.
What genes are involved in iodide transport?
Key genes include SLC5A5 (NIS), SLC26A4 (pendrin), TPO, TG, and TSHR, among others.
How is iodide transported in the thyroid gland?
In the thyroid, iodide is actively taken up at the basolateral membrane by NIS and effluxed into the follicle lumen by pendrin and other transporters.
What diseases are associated with defective iodide transport?
Defective iodide transport causes Pendred syndrome, congenital hypothyroidism, and can influence thyroid and breast cancer.
What is the role of SLC5A5 in iodide transport?
SLC5A5 encodes the sodium/iodide symporter (NIS), which mediates active iodide uptake into cells.
How can I study iodide transport in the lab?
Common methods include radioiodide uptake assays, Ussing chamber, patch-clamp, fluorescent iodide sensors, and CRISPR screens.
What is Pendred syndrome?
Pendred syndrome is a genetic disorder caused by SLC26A4 mutations, leading to goiter and deafness due to defective iodide transport.
Can iodide transport be targeted for cancer therapy?
Yes, radioiodide therapy exploits NIS-mediated iodide uptake in thyroid cancer, and research is exploring its use in breast cancer.
What model systems are used to study iodide transport?
Model systems include knockout mice, patient-derived cells, and CRISPR-engineered cell lines with specific mutations or tags.
How is iodide transport regulated?
It is primarily regulated by TSH, which controls NIS expression and membrane localization, and by iodide itself through autoregulation.
Conclusion
Iodide transport (GO:0015705) is a fundamental biological process required for thyroid hormone synthesis and implicated in a range of diseases, from Pendred syndrome to cancer. Understanding its molecular mechanisms and regulation offers opportunities for therapeutic intervention and improved diagnostics. CRISPR-based models and advanced screening methods are powerful tools to dissect the genetic and cellular basis of iodide transport, paving the way for new discoveries.
References
- 1. Poole VL et al.. 2015. Iodide transport and breast cancer.. J Endocrinol 227(1):R1-R12 PMID: 26285906
- 2. WOLFF J. 1964. TRANSPORT OF IODIDE AND OTHER ANIONS IN THE THYROID GLAND.. Physiol Rev 44:45-90 PMID: 14105583
- 3. Carrasco N. 1993. Iodide transport in the thyroid gland.. Biochim Biophys Acta 1154(1):65-82 PMID: 8507647
- 4. Nilsson M. 1999. Molecular and cellular mechanisms of transepithelial iodide transport in the thyroid.. Biofactors 10(2-3):277-85 PMID: 10609894
- 5. Kopp P et al.. 2008. Pendred syndrome and iodide transport in the thyroid.. Trends Endocrinol Metab 19(7):260-8 PMID: 18692402
- 6. Wémeau JL et al.. 2017. Pendred syndrome.. Best Pract Res Clin Endocrinol Metab 31(2):213-224 PMID: 28648509
- 7. Filetti S et al.. 1999. Sodium/iodide symporter: a key transport system in thyroid cancer cell metabolism.. Eur J Endocrinol 141(5):443-57 PMID: 10576759
- 8. Stephens CE et al.. 2019. (125) Iodide as a surrogate tracer for epithelial chloride transport by the mouse large intestine in vitro.. Exp Physiol 104(3):334-344 PMID: 30615234
